IP Library Granted Patent US 11,382,657
Granted Patent B2
US 11,382,657 · App. 15/999,364 · Granted Jul 12, 2022

Surgical devices with triggered propulsion system for inserting a trocar-cannula assembly

Inventors: Matthew Paul LaConte (Chesterfield, MO); James C. Easley (Cottleville, MO); Jason Stroisch (Wentzville, MO)
Assignee: Synergetics USA, Inc.
A61B17/3421A61B17/3403A61B90/03A61F9/00736A61B17/3462A61B2017/00022A61B2017/00398A61B2017/00477A61B2017/00738A61B2017/3407A61B2017/3409A61B2090/034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,382,657
App. No.
15/999,364
Granted
Jul 12, 2022
Kind
B2
Abstract

Surgical devices and methods of using the surgical devices are disclosed. The surgical devices generally include a trocar, a cannula releasably mounted on the trocar, and a propulsion system operatively connected to the trocar. The cannula includes a hub, and has a central opening through which the trocar extends. The propulsion system is operable to drive the trocar axially in a forward direction away from a proximal end of the surgical device.

Claims (25)

1. A surgical device comprising:

a trocar;

a cannula releasably mounted on the trocar, the cannula including a hub and having a central opening through which the trocar extends;

a propulsion system connected to the trocar and operable to drive the trocar axially in a forward direction away from a proximal end of the surgical device;

a latch; and

a collar connected to the propulsion system by the latch and operable to remove the cannula from the trocar after the propulsion system is activated, wherein the latch disengages the collar following activation of the propulsion system.

2. The surgical device as set forth in claim 1 , wherein the surgical device further includes a positioning member disposed at a distal end of the surgical device, the positioning member including a tapered proximal surface configured to engage the latch and cause the latch to deflect radially outward when the propulsion system is activated.

3. The surgical device as set forth in claim 2 , wherein the latch includes a tapered distal surface that is positioned in axial alignment with the tapered proximal surface of the positioning member.

4. The surgical device as set forth in claim 1 , wherein the collar is connected to the propulsion system by a spring that biases the collar away from the propulsion system and into engagement with the cannula.

5. The surgical device as set forth in claim 4 , wherein the spring biases the trocar in a rearward direction, and wherein the spring is configured to cause the trocar to automatically retract after the propulsion system is activated.

6. The surgical device as set forth in claim 5 , wherein the collar covers a cutting tip of the trocar after the trocar is retracted.

7. The surgical device as set forth in claim 1 , wherein the collar is positioned on the trocar adjacent a proximal end of the cannula.

8. The surgical device as set forth in claim 1 , wherein the collar defines an opening sized to receive the trocar therein, wherein the trocar is freely movable through the opening.

9. The surgical device as set forth in claim 1 , wherein the propulsion system includes a piston moveable between a first, retracted position and a second, extended position upon activation of the propulsion system, wherein the trocar is fixed to the piston.

10. The surgical device as set forth in claim 9 , wherein the latch is connected to the piston, and wherein the latch extends distally past a distal end of the piston to engage the collar.

11. The surgical device as set forth in claim 1 further comprising an activation device operatively connected to the propulsion system and operable to activate the propulsion system in response to a user input.

12. The surgical device as set forth in claim 11 , wherein the activation device includes a trigger extending radially outward from a handle of the surgical device.

13. The surgical device as set forth in claim 1 , wherein the collar comprises a protrusion, and wherein the latch engages the collar via the protrusion.

14. The surgical device as set forth in claim 1 , wherein the latch has a flexible construction and is configured to deflect radially outward to disengage the latch.

15. The surgical device as set forth in claim 1 , wherein the propulsion system includes a first spring that drives the trocar in the forward direction upon activation of the propulsion system, and wherein the surgical device includes a second spring disposed between the collar and the propulsion system, wherein the second spring causes the trocar to automatically retract after the propulsion system is activated.

16. The surgical device as set forth in claim 15 , wherein the second spring is configured to retract the trocar at a velocity of between 0.1 m/s and 1.0 m/s.

17. The surgical device as set forth in claim 1 , wherein the trocar has an outer diameter less than or equal to 23-gauge.

18. The surgical device as set forth in claim 1 , wherein the propulsion system is configured to displace the trocar by a stroke length from an initial position to a second, fully extended position in less than 0.5 seconds.

19. The surgical device as set forth in claim 1 , wherein the surgical device is configured for multiple uses.

20. The surgical device as set forth in claim 1 , wherein the collar is connected to the propulsion system by a spring that biases the collar away from the propulsion system and into engagement with the latch.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: LACONTE, MATTHEW PAUL; EASLEY, JAMES C.; STROISCH, JASON
To: SYNERGETICS USA, INC.
Reel/Frame 060205/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2022
From: LACONTE, MATTHEW PAUL; EASLEY, JAMES C.; STROISCH, JASON
To: SYNERGETICS USA, INC.
Reel/Frame 060188/0181 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Continuity (3)
Continuation In Part 15047404 · Feb 18, 2016
Provisional Application 62345330 · Jun 3, 2016
Related Publication 20190083129A1 · Mar 21, 2019